{"product_id":"rna-analysis-market-by-product-reagents-instruments-software-services-technology-pcr-sequencing-microarrays-rna-interference-application-drug-discovery-clinical-diagnostics-end-user-pharma-biotech-cros-region-global-forecast-to-2028","title":"RNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028","description":"\u003cp\u003eRNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028\u003c\/p\u003e\n\n\u003cp\u003eThe global RNA analysis market size is projected to reach USD 9.9 billion by 2028 from 5.3 billion in 2023, at a CAGR of 13.4% during the forecast period. Factors such as the advancements in the field of transcriptomics studies, and the rising demand for reagents used in RNA analysis due to increased transcriptomics studies supporting the growth of therapeutics are driving the demand for RNA analysis products \u0026amp; services.\u003c\/p\u003e\n\n\u003cp\u003e“The reagents\/consumables segment accounted for the highest growth rate in the RNA analysis market, by product \u0026amp; service, during the forecast period”\u003c\/p\u003e\n\n\u003cp\u003eIn 2022, the reagents\/consumables segment accounted for the highest growth rate. The product \u0026amp; service market is segmented into reagents\/consumables, instruments, services, and software. Expanding applications of peptides in therapeutics, drug design, and gene synthesis and the growing number of ongoing research projects involving RNA analysis contributes to the segment's prominence in the RNA analysis market.\u003c\/p\u003e \n\n\u003cp\u003e“Asia Pacific region is likely to grow at a faster pace.”\u003c\/p\u003e\n\n\u003cp\u003eThe RNA analysis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East \u0026amp; Africa. In 2022, North America accounted for the dominant share of the RNA analysis market. The large share of the region is attributable to various factors such as the presence of leading players in the region paired with the continuing research activities of developing new genomic therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as rising government initiatives for generic medicines in the region, and the emergence of new market players in the RNA analysis market.\u003c\/p\u003e \n\n\u003cp\u003eThe primary interviews conducted for this report can be categorized as follows:\u003c\/p\u003e\n\n\u003cp\u003eBy Respondent: Supply Side- 70%, and Demand Side - 30%\u003c\/p\u003e\n\n\u003cp\u003eBy Designation (Supply Side): Managers - 45%, CXOs \u0026amp; Directors - 30%, Executives- 25%\u003c\/p\u003e\n\n\u003cp\u003eBy Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%\u003c\/p\u003e\n\n\u003cp\u003eLists of Companies Profiled in the Report:\u003c\/p\u003e\n\n\u003cp\u003eThermo Fisher Scientific, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eF. Hoffmann-La Roche Ltd. (Switzerland)\u003c\/p\u003e\n\n\u003cp\u003eBio-Rad Laboratories, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eIllumina, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eEurofins Scientific (Luxembourg)\u003c\/p\u003e\n\n\u003cp\u003eAgilent Technologies, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eMerck KGaA (Germany)\u003c\/p\u003e\n\n\u003cp\u003eDanaher Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003ePromega Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eQIAGEN N.V. (Germany)\u003c\/p\u003e\n\n\u003cp\u003eStandard BioTools (US)\u003c\/p\u003e\n\n\u003cp\u003eSequentia Biotech SL (Spain)\u003c\/p\u003e\n\n\u003cp\u003eAcobiom (France)\u003c\/p\u003e\n\n\u003cp\u003eGenXPro GmbH (Germany)\u003c\/p\u003e\n\n\u003cp\u003eCD Genomics (US)\u003c\/p\u003e\n\n\u003cp\u003ePromega Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eLexogen GmbH (Austria)\u003c\/p\u003e\n\n\u003cp\u003eCenix BioScience GmbH (Germany)\u003c\/p\u003e\n\n\u003cp\u003eTakara Holdings, Inc. (Japan)\u003c\/p\u003e\n\n\u003cp\u003ebioMérieux SA (France)\u003c\/p\u003e\n\n\u003cp\u003eLC Sciences LLC (US)\u003c\/p\u003e\n\n\u003cp\u003eOxford Nanopore Technologies (UK)\u003c\/p\u003e\n\n\u003cp\u003eZymo Research Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eGeneDx (US)\u003c\/p\u003e\n\n\u003cp\u003ePartek Incorporated (US)\u003c\/p\u003e\n\n\u003cp\u003eBGI Group (China)\u003c\/p\u003e\n\n\u003cp\u003eResearch Coverage:\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a detailed picture of the RNA analysis market. It aims at estimating the size and future growth potential of the market across different segments, such the product, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.\u003c\/p\u003e\n\n\u003cp\u003eKey Benefits of Buying the Report:\u003c\/p\u003e\n\n\u003cp\u003eThe report will help market leaders\/new entrants by providing them with the closest approximations of the revenue numbers for the overall RNA analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.\u003c\/p\u003e\n\n\u003cp\u003eThe report provides insights on the following pointers:\u003c\/p\u003e \n\n\u003cp\u003eAnalysis of key drivers (Growing demand for personalized medicine, Rising pharmaceutical and biotechnology R\u0026amp;D expenditure and government funding, and the Increasing applications of RNA sequencing in transcriptomics), restraints (High capital investments), opportunities (High growth opportunities in emerging markets, Increasing applications in toxicogenomics, Increasing focus on biomarker discovery, Rising focus on outsourcing), and challenges (Data management in transcriptomics research, Lack of effective bioinformatics tools, Dearth of skilled professionals.)\u003c\/p\u003e\n\n\u003cp\u003eProduct \u0026amp; Service Development\/Innovation: Detailed insights on newly launched products\/services, and technological assessment of the RNA analysis market.\u003c\/p\u003e\n\n\u003cp\u003eMarket Development: Comprehensive information about lucrative markets – the report analyses the RNA analysis market across varied regions.\u003c\/p\u003e \n\n\u003cp\u003eMarket Diversification: Exhaustive information about new products \u0026amp; services, untapped geographies, recent developments, and investments in the RNA analysis market.\u003c\/p\u003e \n\n\u003cp\u003eCompetitive Assessment: In-depth assessment of market shares, growth strategies, and product \u0026amp; service offerings of leading players like Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg), and among others in the RNA analysis market.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 257 Pages \/ MCW16231474","offer_id":47647319097650,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true},{"title":"July, 2023 \/ 257 Pages \/ MCW16231475","offer_id":47647319130418,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/rna-analysis-market-by-product-reagents-instruments-software-services-technology-pcr-sequencing-microarrays-rna-interference-application-drug-discovery-clinical-diagnostics-end-user-pharma-biotech-cros-region-global-forecast-to-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}